Table 2.
Extent of Family Physician Involvement by Cancer Phase
| Extent of Involvement | N (% of Patients) | PValuea |
|---|---|---|
| Contact with family physician | ||
| Diagnosis | 364 (58.8) | <.001 |
| Primary treatment | 108 (60.2) | |
| Stability | 228 (88.2) | |
| Progression/relapse | 48 (75.0) | |
| Advanced/terminal | 37 (67.6) | |
| If contact with family physician, discussion about visits to oncologist | ||
| Diagnosis | 214 (72.9) | .09 |
| Primary treatment | 65 (77.8) | |
| Stability | 197 (79.7) | |
| Progression/relapse | 36 (91.7) | |
| Advanced/terminal | 22 (83.3) | |
| Questions to ask of family physician in relation to cancer | ||
| Diagnosis | 214 (32.7) | <.001 |
| Primary treatment | 65 (43.1) | |
| Stability | 201 (44.3) | |
| Progression/relapse | 36 (50.0) | |
| Advanced/terminal | 25 (64.0) | |
| Family physician involvement in treatment decisionsb | ||
| Diagnosisc | – | <.001 |
| Primary treatment | 53 (15.1) | |
| Stability | 107 (16.8) | |
| Progression/relapse | 34 (20.6) | |
| Advanced/terminal | 13 (53.9) | |
a From the Cochran-Mantel-Haenszel test; compares, across cancer phases, the proportion of patients who reported each extent of family physician involvement.
b Only for patients who had treatment.
c This question was not asked at the diagnosis phase; often, treatment had already begun at the baseline interview.